Do Tregitopes have the potential to impact the current treatment landscape of autoimmune diseases?
EpiVax, Inc., 146 Clifford St, Providence, RI 02903, USA and University of Rhode Island, Institute for Immunology and Informatics, RI, USA +1 401 272 2123 +1 401 272 7562 dr.annie.degroot@gmail.com; annied@epivax.com.
Anne S
AS
De Groot
D000818:Animals; D001327:Autoimmune Diseases / Q000276:immunology* / Q000628:therapy*; D006801:Humans; D016056:Immunodominant Epitopes / Q000276:immunology*; D007167:Immunotherapy / Q000639:trends; D050378:T-Lymphocytes, Regulatory / Q000276:immunology*
D016056:Immunodominant Epitopes